Healthcare - Biotechnology - NASDAQ - US
$ 0.9386
-6.14 %
$ 270 M
Market Cap
-5.21
P/E
CASH FLOW STATEMENT
-62.1 M
OPERATING CASH FLOW
3.08 M
INVESTING CASH FLOW
20.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ocugen, Inc.
| Net Income | -63.1 M |
| Depreciation & Amortization | 704 K |
| Capital Expenditures | -10.5 M |
| Stock-Based Compensation | 9.22 M |
| Change in Working Capital | -13.2 M |
| Others | -8.9 M |
| Free Cash Flow | -72.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (63.1) | (81.4) | (58.4) | (21.8) | (20.2) | (8.6) | (26.4) | (16.2) | (32.0) | (22.8) | (25.7) | (16.9) |
| Depreciation & Amortization | 0.7 | 0.5 | 0.2 | 0.1 | 60.6 K | 0.5 | 1.5 | 1.7 | 1.6 | 0.7 | 0.6 | 0.6 |
| Deferred Income Tax | 0 | 0 | 52 K | 0 | 3.2 | (17.1) | 1.5 | (14.2) | 0.3 | 60 K | 80 K | 2.4 |
| Stock Based Compensation | 9.2 | 10.5 | 7.0 | 0.7 | 0.9 | 1.6 | 1.6 | 1.5 | 1.2 | 0.5 | 0.2 | 14 K |
| Other Operating Activities | 4.3 | 1.1 | 0.8 | 7.6 | 2.3 | 10.7 | (0.5) | (0.5) | (0.3) | 0.7 | 8.4 | 1.6 |
| Change in Working Capital | (13.2) | 9.2 | 2.5 | (1.2) | (3.1) | (2.8) | (0.7) | 2.0 | (0.9) | 2.4 | 1.3 | 48 K |
| Cash From Operations | (62.1) | (60.1) | (47.9) | (14.7) | (16.9) | (15.8) | (23.0) | (25.7) | (30.0) | (18.4) | (15.3) | (12.2) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (10.5) | (4.5) | (0.9) | (0.3) | 29.4 K | (2.0) | (0.3) | (0.3) | (1.9) | (3.3) | (0.6) | 79 K |
| Other Items | 13.6 | (12.5) | (0.9) | 0 | (2.3) | 0.9 | (1.0) | 0 | 0 | 0 | 50 K | 0 |
| Cash From Investing Activities | 3.1 | (17.0) | (1.8) | (0.3) | (2.4) | (1.1) | (1.2) | (0.3) | (1.9) | (3.3) | (0.6) | 79 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 48 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0.5 | 0.5 | 10 K | (4.7) | 1.4 | (0.2) | (0.6) | (0.6) | (0.4) | 1.8 | 0 | 6.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.4) | (1.1) | (8.5) | (1.5) | 22.5 | 3 K | 6 K | 2 K | 39 K | 8.9 | 9.9 | 20.7 |
| Cash From Financing Activities | 20.9 | 59.5 | 120.7 | 31.6 | 25.1 | 25.4 | (0.6) | 27.0 | 4.4 | 71.1 | 9.9 | 26.7 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (38.1) | (17.5) | 70.9 | 16.6 | 5.8 | 8.5 | (24.8) | 1.0 | (27.6) | 49.3 | (6.0) | 14.4 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (72.5) | (64.5) | (48.9) | (15.0) | (16.9) | (17.8) | (23.3) | (26.1) | (32.0) | (21.7) | (15.9) | (12.3) |